Menu

BioNTech SE BNTX

Full chart Compare
Set alert

Price alert · BNTX

All alert types
87.65 USD +0.44 (+0.50%)

At closeNov 12, 2026, 7:14 AM EST

86.78 -0.87 -0.99%

Pre-market · Nov 12, 7:14 AM ET

86.30 Day range 87.73
79.52 52-week range 124.00
YTD
-7.93%
1 year
-19.33%

Discussion (397)

Sign in to join the discussion

Voice of Reason BNTX 6 years ago #261

Tweets & replies
Media
Likes
BioNTech SE’s Tweets

BioNTech SE
@BioNTech_Group
·
2h
We are excited to welcome the latest addition to the BioNTech family: our colleagues in Marburg. The tech transfer is currently being made and we plan to start the production of potential #COVID19 vaccines in 2021. Welcome to #TeamBioNTech!

Voice of Reason BNTX 6 years ago #262

You have to remember there’s already some $ built into the evaluation. It’s my opinion it’s jumps 30% on initial report. I think there’s a possibility of people over buying. So maybe even 40%. Don’t forget most adverse effects occur after 2nd month of vaccine., so as time goes by, the price should continue to grow. Additional price increases would come from the failures of other vaccines because there would be less competition. The cost to make the vaccine and the ability to deliver it would be other major factors. So I don’t think anyone will know the value of this stock until Spring of next year when all the other vaccines are on play.

Voice of Reason BNTX 6 years ago #263

Once the panic cools off we should see buys in about 2 hrs.

Voice of Reason BNTX 6 years ago #264

It’s only red because entire US markets are red. If market bounces back some this afternoon, then BNTX will too.

Cosmic BNTX 6 years ago #265

$BNTX I think they’ll announce the good results right after the elections are complete. Will be a best news ever and $BNTX will skyrocket.

Voice of Reason BNTX 6 years ago #268

GERMAN WEBSITE:

When is the vaccine coming? Interview with Biontech boss Sahin
When will a corona vaccine come? And who delivers it? Today from 4 p.m. Ugur Sahin, head of the promising pharmaceutical developer Biontech in Mainz, will give answers in a live interview.

MAINZ - The whole world is looking at the Mainz biopharma developer Biontech these days. The company could be among the very first in the world to receive approval for a vaccine to protect against corona infections. This Thursday, October 29th, 4 p.m., Prof. Ugur Sahin, the CEO of Biontech, will answer the questions of Friedrich Roeingh and Christian Matz in a live interview with the VRM: Can a vaccine even meet the excessive expectations of it? When can we expect the Biontech vaccine and other vaccines? How effective can they be? Will we finally return to normal life as we knew it before Corona? With such a short development time, can side effects be reliably assessed and long-term damage excluded? How long it will take,until people in Europe and around the world can be supplied with enough vaccine?